National Institute for Health and Care Excellence (NICE)
The National Institute for Health and Care Excellence (NICE) is the UK body with responsibility for assessing new products. It is their appraisal that decides whether a medicine can be given to patients through the NHS, considering its efficacy, its cost-effectiveness, and its performance compared to existing treatments.
NICE primarily issue advice in the form of Guidelines and Technology Appraisals Guidance. Our NICE pages cover these topics in detail, walking you through the whole process and possible outcomes. We also discuss how topics are selected by NICE, as well as more specialised topics such as the Cancer Drugs Fund (CDF) and NICE Scientific Advice.
Membership required to access MAP Online
Benefits of a membership to MAP Online include:
- Access to up-to-date, validated and detailed market access guides
- Downloadable tools, slide decks, flowcharts and more...
- Free workshops with every new membership to help you get the most out of MAP